Data Foundry

Drug recalls 2022

Meijer allergy relief — Class II drug recall D-0343-2022

Terminated recall by Perrigo Company PLC, reported 2022-01-12, distributed nationwide. Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stabi

Recall numberD-0343-2022
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmPerrigo Company PLC, Allegan, MI, United States
Recall initiated2021-07-27
Classified2022-01-05
Reported by FDA2022-01-12
Terminated2022-11-08
DistributedNationwide (US)
Quantity4,536 containers
Reason classesspecification failure
UPC / GTIN / UDI-DI00760236187165, 00760236187172, 00760236187325
NDC41250-0060-22, 41250-0060-39, 41250-0060-95
Expiration dates2021-12-31, 2022-02-28, 2022-06-30, 2022-10-31

Product

Meijer allergy relief, Fexofenadine Hydrochloride tablets, 24HR, 1800mg Antihistamine, packaged as a) 15 count bottle, NDC 41250-060-22 UPC 7 60236 18716 5; b) 30 count bottle, NDC 41250-060-39, UPC 7 60236 18717 2; c) 45 count bottle, NDC 41250-060-95, UPC 7 60236 18732 5; Made in the Czech Republic, Distributed by Meijer Distribution Inc, Grand Rapids, MI 49544.

Reason for recall

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0343-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.